PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity

Patricio Oyarzún, Jonathan J. Ellis, Mikael Bodén, Bostjan Kobe. PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity. BMC Bioinformatics, 14:52, 2013. [doi]

Possibly Related Publications

The following publications are possibly variants of this publication: